Export

Rituximab
Essential medicine status
General description
Rituximab is a monoclonal antibody used in treatment protocols for lymphomas and leukaemia, as well as various autoimmune inflammatory diseases.
INN
Rituximab
Medicine type
Biological agent
Therapeutic equivalent for
Wikipedia
DrugBank
Recommendations
Section
Targeted therapies
  • Parenteral > General injections > IV: 100 mg per 10 mL in 10 mL vial; 500 mg per 50 mL in 50 mL vial